You are here: Industry Insights > china

News List

AstraZeneca allies with Alibaba and Tencent as its China sales soar fiercepharma
February 05, 2018
AstraZeneca is now stepping up its game there through two new deals with Chinese internet giants Alibaba and Tencent.
Update on Priority Review by CDE: Acceptance of First CAR-T Therapy Clinical Application cccmhpie
February 02, 2018
On December 11, 2017, the first CAR-T project clinical application in China (CXSL1700201) filed by Nanjing Legend Biotechnology Co., Ltd. (hereinafter referred to as Nanjing Legend) was formally undertaken and accepted by the CDE
Update on Priority Review by CDE: Biggest Bright Spot Being the Inclusion of Novartis’ LCZ696 cccmhpie
January 31, 2018
CDE publicized on December 2 the twelfth batch of registration applications of pharmaceutical products to be included in the priority review procedure, with 32 acceptance numbers in total included in the list.
Let Data Talk: Is Nature or Humans to Blame for the Outbreak of Influenza this Winter? (2) Mr. Nanguo
January 29, 2018
Influenza: A natural disaster due to WHO’s errors in predicting influenza strains?
Let Data Talk: Is Nature or Humans to Blame for the Outbreak of Influenza this Winter? (1) Mr. Nanguo
January 29, 2018
Influenza has started to outbreak in China recently...
China AI biotech XtalPi lands $15M from Sequoia, Google, Tencent fiercebiotech
January 26, 2018
As capital continues to pile onto applications of artificial intelligence in drug R&D, XtalPi, a Chinese startup working in that field, has secured a $15 million series B backed by high-profile tech investors Sequoia China, Google and Chinese internet gia
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs? (2) Y-lp.com
January 26, 2018
The blood lipid regulating drugs are second only to the antineoplastic chemical drugs both on the Chinese and global markets. Statins account for about 90% share on the blood lipid regulating prescription drug market in China.
Mundipharma signs Chinese licensing and distribution agreement with Grünenthal pharmafile
January 17, 2018
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on behalf of Grünenthal, it has emerged.
China launches the largest human genome research project biospectrumasia
January 02, 2018
There are about 25,000 human genes and the project aims to decode the hereditary information contained in each.
Infinitus Certified as a Top Employer in China for Three Consecutive Years prnasia
December 06, 2017
Distinguished Employer Institute released a list of China's leading employers in 2018 in Shanghai on December 4, 2017

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page